Home / R3HDM1 Knockout Cell Lines

R3HDM1 Knockout Cell Lines

Gene: R3HDM1

Official Full Name: R3H domain containing 1provided by HGNC

Gene Summary: Enables RNA binding activity. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO29211 R3HDM1 Knockout cell line (HeLa) Human R3HDM1 1:3~1:6 Negative Online Inquiry
KO29212 R3HDM1 Knockout cell line (HCT 116) Human R3HDM1 1:2~1:4 Negative Online Inquiry
KO29213 R3HDM1 Knockout cell line (HEK293) Human R3HDM1 1:3~1:6 Negative Online Inquiry
KO29214 R3HDM1 Knockout cell line (A549) Human R3HDM1 1:3~1:4 Negative Online Inquiry

Background

R3HDM1 Gene Knockout Cell Lines represent a cutting-edge innovation in genetic research, specifically designed for elucidating the functional roles of the R3HDM1 gene in various biological processes. These cell lines have been meticulously engineered to possess a targeted knockout of the R3HDM1 gene, providing researchers with a vital tool to investigate gene function, signaling pathways, and molecular mechanisms underlying disease progression.

The primary function of the R3HDM1 gene knockout cell lines is to facilitate in-depth studies on the gene's role in cellular processes, including RNA metabolism, immune response, and stress signaling pathways. By removing the R3HDM1 gene, these cell lines allow for easier observation of compensatory mechanisms and downstream effects, offering a clearer understanding of gene interactions and protein functions. This knockout model empowers researchers to discern phenotypic changes due to the absence of R3HDM1, thus aiding in the identification of critical biomarkers for disease.

The scientific importance of R3HDM1 knockout cell lines is underscored by their potential applications in both fundamental research and clinical settings. Specifically, these cell lines can be utilized in drug discovery and development, preclinical studies, and disease modeling. Their utility extends across a range of applications, from investigating oncogenesis to exploring neurodegenerative diseases. These cell lines enable researchers to develop targeted therapies and diagnostic tools that are crucial in modern medicine.

One distinctive advantage of R3HDM1 Gene Knockout Cell Lines is their high specificity and reliability, made possible by advanced CRISPR/Cas9 gene-editing technology, ensuring precise gene disruption. Compared to traditional knockout methods, this technology reduces off-target effects and variations in results, yielding more consistent and reproducible data. As a result, these cell lines provide researchers with confidence in their experimental outcomes, enhancing the validity of their findings.

For researchers, clinicians, and biotechnologists seeking to expand their investigative horizons, R3HDM1 knockout cell lines represent an invaluable resource that accelerates discovery and innovation in gene-function studies. By providing clear insights into gene activity and its implications in pathological conditions, these cell lines contribute significantly to the advancement of personalized medicine and targeted therapies.

Our company specializes in the development of high-quality, genetically engineered cell lines and possesses extensive expertise in gene editing and cellular biology. By leveraging state-of-the-art technologies, we are committed to supporting researchers in their quest for biological and medical breakthroughs.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.